Sunday, December 8, 2013

Study Indicates Highly Effective HPV Vaccine Is Underutilized

Cancer is a dirty word. For some, so is vaccination. And where these two circles collide, a deadly disease can flourish. The Human Papillomavirus (HPV) vaccine is an easy, highly effective way to prevent some of the most grisly cancers known to man; however, a new study conducted by the American Cancer Society suggests that the very people who would benefit most strongly from its protection are all too often unaware of its value.

HPV refers to a group of over 150 viruses that infect the superficial cells of the cervix, genitals, anus, and throat. The virus enters these surface cells, also known as epithelial cells, through minuscule cuts or abrasions made during sexual contact. One inside the cell, the virus hijacks the nucleus and replicates its own genetic code tens or hundreds of times. The infected host can then transmit the virus to his or her sexual partner(s), and the cycle begins again. In fact, HPV is the most common sexually transmitted disease in the country and is estimated to affect more than 50% of the population at some point during their lives.

It can take months or even years to detect an HPV infection, partly because many individuals who carry the virus show no symptoms. Those who do often develop genital warts, the so-called papillomas from which the virus derives its name. Most host immune systems are ultimately able to clear the virus without treatment, but some will go on to develop abnormal cells in the affected area. These cells carry a high risk for unregulated growth and proliferation; unchecked, they can blossom into malignancy - the driving force behind cancer.

Fortunately, HPV is preventable - but only if an individual is immunized before coming into contact with the virus. This means that vaccination is most effective when given in early adolescence. The HPV vaccine consists of a three-dose series: one dose, followed by another 1-2 months later, and a final dose 6 months after the first. Two vaccines against HPV have been approved by the FDA: Gardasil and Cervarix. Both of these shots can be given starting at age 9, and protect against the viral strains that cause most cancers, HPV16 and HPV18. Gardasil also fights HPV6 and HPV11, two of the strains that often cause genital warts.

Despite the fact that these immunizations are widely available, many of those who are at risk for contracting HPV and related cancers know surprisingly little about their existence or effectiveness. At a conference in Atlanta this past weekend, the American Cancer Society's director of health disparities research, Kassandra I. Alcaraz, spoke about a recent survey that revealed a need for better education regarding HPV vaccination among medically underserved populations. Out of more than 1400 individuals who were targeted for their high-risk status, only 30% reported an understanding of the benefits of the HPV vaccine. This percentage dropped to just 22% for non-Hispanic Black respondents. More than three-quarters of respondents reported never having spoken to their doctor about the vaccine at all. Meanwhile, the underserved, minority populations targeted for this study - low-income, Black, and Hispanic women - tend to experience a much higher incidence of HPV-related cancers and die from them at much higher rates than their white, middle-to-upper class counterparts.

Alcaraz also noted that only a third of teenage girls are immunized with the full HPV series, a number that markedly undermines the ACS's wider goal of primary prevention. In short, she said, “the HPV vaccine is a long way from reaching its potential.”

Health care providers can improve this situation not only by discussing the shot with all patients (and parents of patients) who are eligible to receive it, but also by heavily emphasizing its effectiveness. In Alcaraz's view, this is the most pressing concern. "Uncertainty [about the vaccine's effectiveness] may influence decision-making about getting vaccinated," she said. "It hinders our ability to reduce cervical cancer incidence and mortality and reduce disparities in cervical cancer." Alcaraz continued, "Our research suggests efforts should go beyond merely increasing awareness of the availability of the vaccine and focus on making sure people know it is effective.”

As always, those on the front lines of the fight against vaccine-preventable diseases have their work cut out for them.

Monday, January 9, 2012

Tracing Dark Matter with Ripples in the Whirlpool Galaxy

A new paper presented at this week’s American Astronomical Society conference promises to shine some light, so to speak, on the pursuit of dark matter in individual galaxies. The current model of cold dark matter in the Universe is extremely successful when it comes to mapping the mysterious substance on large scales, but not on galactic and sub-galactic scales. Earlier today, Dr. Sukanya Chakrabarti of Florida Atlantic University described a new way to map dark matter by observing ripples in the hydrogen disks of large galaxies. Her work may finally allow astronomers to use their observations of ordinary matter to probe the distribution of dark matter on smaller scales.
Read more...

Full story at Universe Today.

Thursday, January 5, 2012

Unlocking Cosmology With Type 1a Supernovae

Let's face it, cosmologists catch a lot of flack. It's easy to see why. These are people who routinely publish papers that claim to ever more finely constrain the size of the visible Universe, the rate of its breakneck expansion, and the distance to galaxies that lie closer and closer to the edges of both time and space. Many skeptics scoff at scientists who seem to draw such grand conclusions without being able to directly measure the unbelievable cosmic distances involved. Well, it turns out cosmologists are a creative bunch. Enter our star (ha, ha): the Type 1a Supernova. These stellar fireballs are one of the main tools astronomers use in order to make such fantastic discoveries about our Universe. But how exactly do they do it?
Read more...

Full story at Universe Today.

Friday, August 5, 2011

Testing the Multiverse... Observationally!

The multiverse theory is famous for its striking imagery. Just imagine our own Universe, drifting among a veritable sea of spontaneously inflating “bubble universes”, each a self-contained and causally separate pocket of higher-dimensional spacetime. It’s quite an arresting picture. However, the theory is also famous for being one of the most criticized in all of cosmology. Why? For one, the idea is remarkably difficult, if not downright impossible, to test experimentally. But now, a team of British and Canadian scientists believe they may have found a way.
Read more...

Full story at Universe Today.

Friday, July 1, 2011

Ancient Galaxies Fed On Gas, Not Collisions

The traditional picture of galaxy growth is not pretty. In fact, it’s a kind of cosmic cannibalism: two galaxies are caught in ominous tango, eventually melding together in a fiery collision, thus spurring on an intense but short-lived bout of star formation. Now, new research suggests that most galaxies in the early Universe increased their stellar populations in a considerably less violent way, simply by burning through their own gas over long periods of time.
Read more...

Full story at Universe Today.

Most Distant Quasar Opens Window Into Early Universe

Astronomers have uncovered yet another clue in their quest to understand the Universe’s early life: the most distant quasar ever observed. At a redshift of 7.1, it is a relic from when the cosmos was just 770 million years old – just 5% of its age today.
Read more...

Full story at Universe Today.